Name (Synonyms) | Correlation | |
---|---|---|
drug942 | FilmArray Pneumonia Wiki | 1.00 |
drug2727 | acetylsalicylic acid Wiki | 1.00 |
drug2597 | Unfractionated heparin nebulized Wiki | 1.00 |
drug852 | Enoxaparin Wiki | 0.33 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Hypercoagulability has been demonstrated in COVID-19, leading to respiratory distress and increased mortality. This is adaptive clinical trial to compare effectiveness and safety of four therapeutic strategies in hospital mortality in patients with COVID-19: standard prophylaxis, therapeutic dose anticoagulation, inhaled UFH associated with standard prophylaxis and ASA associated with standard prophylaxis.
Description: Number of COVID-19 positive patients who are alive within 30 days of symptoms onset
Measure: Hospital discharge - alive / death Time: 30 daysDescription: Comparison of length of mechanical ventilation free days between each treatment arm
Measure: Length of mechanical ventilation free days Time: 30 daysDescription: Comparison of length of renal replacement therapy free days between each treatment arm
Measure: Length of renal replacement therapy free days Time: 30 daysDescription: Comparison of number of thrombosis events between each treatment arm.
Measure: Number of documented venous thromboembolism or arterial thrombosis Time: 3 months